Size | Price | Stock | Qty |
---|---|---|---|
500mg |
|
||
1g |
|
||
Other Sizes |
|
Targets |
Microbial Metabolite Human Endogenous Metabolite
|
---|---|
ln Vitro |
In Escherichia coli, alpha-ketoisovaleric acid, or sodium 3-methyl-2-oxobutanoate, is a precursor to pantothenic acid[1]. Alpha-ketoisovaleric acid, also known as sodium 3-methyl-2-oxobutanoate, increases alpha-ketoisocaproic acid and alpha-keto-beta-methyl-n-valeric acid. However, it also depletes the corresponding amino acids and results in an early decrease in ornithine and a late increase in plasma arginine[2].
|
ln Vivo |
In rats, convulsions are induced by sodium 3-methyl-2-oxobutanoate (alpha-ketoisovaleric acid) via GABAergic and glutamatergic mechanisms[3].
|
References |
|
Additional Infomation |
Sodium-3-methyl-2-oxobutyrate is an oxo carboxylic acid.
|
Molecular Formula |
C5H7NAO3
|
---|---|
Molecular Weight |
138.10
|
Exact Mass |
138.029
|
CAS # |
3715-29-5
|
Related CAS # |
3-Methyl-2-oxobutanoic acid;759-05-7;Sodium 3-methyl-2-oxobutanoate-13C4,d4;1185115-88-1;Sodium 3-methyl-2-oxobutanoate-13C2,d;1216972-87-0;Sodium 3-methyl-2-oxobutanoate-d hydrate;Sodium 3-methyl-2-oxobutanoate-13C4,d3;1215605-14-3;Sodium 3-methyl-2-oxobutanoate-13C,d4;1202865-40-4;Sodium 3-methyl-2-oxobutanoate-13C,d4-1;2483824-45-7;Sodium 3-methyl-2-oxobutanoate-13C5;1173018-24-0;3-Methyl-2-oxobutanoic acid-13C2;634908-42-2;Sodium 3-methyl-2-oxobutanoate-d7;2483831-46-3;Sodium 3-methyl-2-oxobutanoate-13C2,d4;1007477-29-3
|
PubChem CID |
2724059
|
Appearance |
White to light brown solid powder
|
Boiling Point |
170.2ºC at 760 mmHg
|
Melting Point |
220-230 °C (dec.)(lit.)
|
Hydrogen Bond Donor Count |
0
|
Hydrogen Bond Acceptor Count |
3
|
Rotatable Bond Count |
2
|
Heavy Atom Count |
9
|
Complexity |
119
|
Defined Atom Stereocenter Count |
0
|
InChi Key |
WIQBZDCJCRFGKA-UHFFFAOYSA-M
|
InChi Code |
InChI=1S/C5H8O3.Na/c1-3(2)4(6)5(7)8;/h3H,1-2H3,(H,7,8);/q;+1/p-1
|
Chemical Name |
sodium;3-methyl-2-oxobutanoate
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
H2O: 125 mg/mL (905.14 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (724.11 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
 (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 7.2411 mL | 36.2056 mL | 72.4113 mL | |
5 mM | 1.4482 mL | 7.2411 mL | 14.4823 mL | |
10 mM | 0.7241 mL | 3.6206 mL | 7.2411 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.